The use of the red cell surface antigen to predict the malignant potential of transitional cell carcinoma of the ureter and renal pelvis.
This is the first report on the use of the red cell surface antigen test in predicting the malignant potential of transitional cell carcinoma of the ureter and renal pelvis. In 29 cases evaluated there was an 80 per cent correlation. The red cell surface antigen determination was shown to have practical value in the management of these tumors.
D000954:Antigens, Surface / Q000276:immunology*; D002295:Carcinoma, Transitional Cell / Q000175:diagnosis* / Q000276:immunology / Q000473:pathology; D002448:Cell Adhesion; D004912:Erythrocytes / Q000276:immunology*; D006801:Humans; D007680:Kidney Neoplasms / Q000175:diagnosis / Q000276:immunology / Q000473:pathology; D007682:Kidney Pelvis / Q000473:pathology*; D014516:Ureteral Neoplasms / Q000175:diagnosis* / Q000276:immunology / Q000473:pathology; D001749:Urinary Bladder Neoplasms / Q000150:complications / Q000473:pathology
D000954:Antigens, Surface